In the first full-scale revision since 2004, new guidelines for the management of ST-segment elevation myocardial infarction (STEMI) focus on clinical decision making at all stages, from early ...
AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised “Guidelines on the Management ...
BARCELONA, Spain—The European Society of Cardiology (ESC) has issued new guidelines for the management of acute MI patients presenting with ST-segment elevation, placing a new emphasis on the use of ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Most patients with cocaine-associated chest pain were observed by cardiologists and emergency ...
When timely angioplasty is unavailable to older ST-segment elevation myocardial infarction (STEMI) patients, a modified pharmaco-invasive reperfusion strategy could be reasonable, according to the ...
ORLANDO -- Among younger ST-segment elevation MI (STEMI) patients who can't get primary angioplasty in time, and wind up getting fibrinolytics as the main reperfusion therapy, subsequent ticagrelor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results